Advertisement

Topics

Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase

2019-03-05 02:29:15 | BioPortfolio

Published on BioPortfolio: 2019-03-05T02:29:15-0500

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

Evaluation of PKU Sphere

A prospective, open-label study of PKU Sphere in patients with PKU following a phenylalanine restricted therapeutic diet.

A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels

The primary objective of this trial is to evaluate the safety and tolerability of long-term Phenoptin treatment in subjects with PKU.

Gene Therapy Clinical Study in Adult PKU

This is a Phase 1/2, open-label, randomized, concurrently-controlled, dose escalation study to evaluate the safety and efficacy of HMI-102 in adult PKU subjects with PAH deficiency. Partic...

A 16 Week Study Evaluating the Introduction of a GMP Based Protein Substitute in Participants With PKU

This study aims to measure changes in participants' blood phenylalanine (Phe) levels in participants with PKU when switching from a conventional amino acid based protein substitute to a GM...

Nutrition Status of Adults Treated With Pegvaliase

Conduct a cross-sectional analysis of the nutritional status of individuals with PKU treated with pegvaliase for greater than one year. We will evaluate laboratory markers of nutritional s...

PubMed Articles [0 Results]

None

Medical and Biotech [MESH] Definitions

An enzyme of the oxidoreductase class that catalyzes the formation of L-TYROSINE, dihydrobiopterin, and water from L-PHENYLALANINE, tetrahydrobiopterin, and oxygen. Deficiency of this enzyme may cause PHENYLKETONURIAS and PHENYLKETONURIA, MATERNAL. EC 1.14.16.1.

A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952).

More From BioPortfolio on "Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial